ARCHIVES

Crout Resigns As Director Of FDA Drugs Bureau

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

October 29, 2004

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

Lame-Duck Session Required To Complete HHS Funding Bill; Nobel Laureates For Gore.

November 10, 2000

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983